Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies

Abstract

Results of this prospective cohort study suggest an association between antidrug antibodies and nonresponse to bDMARDs in patients with RA. Monitoring antidrug antibodies could be considered in the treatment of these patients, particularly nonresponders to biologic RA drugs.